Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-Tn-MUC1 Vaccine in Non-Metastatic Castration-Resistant Prostate Cancer
NCT00852007Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Feb 2009
- Primary completion
- Feb 2014
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DC-Tn-MUC1 in prostate cancer (PCa), sponsored by Hamilton Health Sciences. Started Feb 2009; status: completed.
02
Drugs
DC-Tn-MUC1
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00852007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852007.